Member Info for PhatStyle4321

This short term is an opportunity to top and will be over 70p soon, the fund is panic selling due to mismanaging and needing cash.

Get in before it rockets

Like yesterday at the US open it rocketed and at these prices it is a steal, load up before

Exactly what happened last time this rocketed to 14p, get your shares before investor notice the news

Has the fireworks finally been let out ?

Share price very undervalued here, one huge step they have gained and now the company is more derisked. I suspect a big increase today once wider market catchs on

Tree shake before blast to 100p, it did this last time and took off 77p

Worth billions !!!!

Wow what is happening!!!! 100p plus incoming

This treatment is worth billions not millions, all this investment and 4D pharma pulled it off. Merck knew the value here and hence kept investing.

This is just incredible !!!!

Wow it’s going mental, take over incoming

A friend of mine told me when they want something they just buy it out, IMO it would a smart move for them so this could be a possibility here? Food for thought

Apparently Merck are mulling a takeover to take the product? If true what price would they pay here ? IMO would be a nice move

Certainly bodes well for the rest of the week, 30p incoming especially on news of IOS 9 production

This is absolutely great value and rumours have it more RNS’s to land imminently

Anyone deramping this is only wanting to get a lower entry

This is the first step on commercialisation and on top of that it is with the NHS !! That is absolutely huge, another big aspect of the rise will be the short squeeze that GSA capital will have to buy back over 4,000,000 shares.

Due to the late RNS I could only assume GSA were caught off guard and will be looking to get out Monday, I can see them having to buy back these shares in a very big hurry. Monday should be interesting but I believe it will be another 105 % day. Over 60p finish

https://www.shorttracker.co.uk/company/GB00B1VKB244/

While investors digest this news over the weekend, people will start to realise how amazing this news is and the price will rocket.

Remember that GDR rose to 80p without any revenues, also if successful then it will be rolled out to every NHS

I believe that there is going to be a short squeeze next week, GSA Capital will definitely be wanting to buy back after this transformational news.

They are also important as their routine use will serve as a model for other Trust and NICU's looking for innovative ways to improve patient safety and overall outcomes. This is a cornerstone installation for us as we commercialise our unique AIHL assay.